• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

目前蟑螂过敏原免疫治疗的实践和未来趋势。

Current practices and future trends in cockroach allergen immunotherapy.

机构信息

Department of Biological Sciences, School of Medical and Life Sciences, Sunway University, Bandar Sunway 47500, Selangor, Malaysia.

Department of Biological Sciences, Faculty of Science, National University of Singapore, 117543, Singapore.

出版信息

Mol Immunol. 2023 Sep;161:11-24. doi: 10.1016/j.molimm.2023.07.004. Epub 2023 Jul 20.

DOI:10.1016/j.molimm.2023.07.004
PMID:37480600
Abstract

PURPOSE OF REVIEW

This review evaluates the current modes of allergen-specific immunotherapy for cockroach allergens, in terms of clinical outcomes and explores future trends in the research and development needed for a more targeted cockroach immunotherapy approach with the best efficacy and minimum adverse effects.

SUMMARY

Cockroach allergy is an important risk factor for allergic rhinitis in the tropics, that disproportionately affects children and young adults and those living in poor socio-economic environments. Immunotherapy would provide long-lasting improvement in quality of life, with reduced medication intake. However, the present treatment regime is long and has a risk of adverse effects. In addition, cockroach does not seem to have an immuno-dominant allergen, that has been traditionally used to treat allergies from other sources. Future trends of cockroach immunotherapy involve precision diagnosis, to correctly identify the offending allergen. Next, precision immunotherapy with standardized allergens, which have been processed in a way that maintains an immunological response without allergic reactions. This approach can be coupled with modern adjuvants and delivery systems that promote a Th1/Treg environment, thereby modulating the immune response away from the allergenic response.

摘要

目的综述

本综述评估了目前针对蟑螂过敏原的变应原特异性免疫疗法的临床疗效,并探讨了未来在研究和开发方面的趋势,以期针对蟑螂免疫疗法进行更有针对性的研究,从而达到最佳疗效和最小不良反应。

摘要

蟑螂过敏是热带地区过敏性鼻炎的一个重要危险因素,它不成比例地影响儿童和青年以及生活在贫困社会经济环境中的人。免疫疗法可以改善生活质量,减少药物的摄入。然而,目前的治疗方案时间长,且有不良反应的风险。此外,蟑螂似乎没有免疫优势过敏原,而传统上使用该过敏原来治疗其他来源的过敏。蟑螂免疫疗法的未来趋势涉及精确诊断,以正确识别过敏原。接下来,使用标准化过敏原进行精准免疫治疗,这些过敏原经过处理后可以保持免疫反应而不引起过敏反应。这种方法可以与现代佐剂和输送系统结合使用,促进 Th1/Treg 环境,从而调节免疫反应,避免过敏原反应。

相似文献

1
Current practices and future trends in cockroach allergen immunotherapy.目前蟑螂过敏原免疫治疗的实践和未来趋势。
Mol Immunol. 2023 Sep;161:11-24. doi: 10.1016/j.molimm.2023.07.004. Epub 2023 Jul 20.
2
Cockroach allergy and allergen-specific immunotherapy in asthma: potential and pitfalls.哮喘中的蟑螂过敏与变应原特异性免疫疗法:潜力与陷阱
Curr Opin Allergy Clin Immunol. 2014 Dec;14(6):535-41. doi: 10.1097/ACI.0000000000000106.
3
New Insights into Cockroach Allergens.蟑螂过敏原的新见解
Curr Allergy Asthma Rep. 2017 Apr;17(4):25. doi: 10.1007/s11882-017-0694-1.
4
Cockroach allergen component analysis of children with or without asthma and rhinitis in an inner-city birth cohort.城市内出生队列中有无哮喘和鼻炎的儿童的蟑螂过敏原成分分析。
J Allergy Clin Immunol. 2019 Oct;144(4):935-944. doi: 10.1016/j.jaci.2019.05.036. Epub 2019 Jun 13.
5
Cockroach allergens and asthma in Brazil: identification of tropomyosin as a major allergen with potential cross-reactivity with mite and shrimp allergens.巴西的蟑螂过敏原与哮喘:将原肌球蛋白鉴定为一种主要过敏原,它可能与螨虫和虾类过敏原发生交叉反应。
J Allergy Clin Immunol. 1999 Aug;104(2 Pt 1):329-37. doi: 10.1016/s0091-6749(99)70375-1.
6
Prevalence of sensitivity to cockroach allergens and IgE cross-reactivity between cockroach and house dust mite allergens in Chinese patients with allergic rhinitis and asthma.中国过敏性鼻炎和哮喘患者对蟑螂过敏原的敏感性及蟑螂和屋尘螨过敏原之间 IgE 交叉反应性的流行情况。
Chin Med J (Engl). 2010 Dec;123(24):3540-4.
7
Allergen immunotherapy in allergic rhinitis: current use and future trends.变应性鼻炎的变应原免疫治疗:当前应用与未来趋势。
Expert Rev Clin Immunol. 2017 Sep;13(9):897-906. doi: 10.1080/1744666X.2017.1333423. Epub 2017 Jun 15.
8
Recombinant allergens for diagnosis and immunotherapy of allergic disorders, with emphasis on cockroach allergy.用于过敏性疾病诊断和免疫治疗的重组变应原,重点是蟑螂过敏。
Curr Protein Pept Sci. 2006 Feb;7(1):57-71. doi: 10.2174/138920306775474112.
9
Allergen specific sublingual immunotherapy in children with asthma and allergic rhinitis.变应原特异性舌下免疫治疗在哮喘和变应性鼻炎患儿中的应用。
World J Pediatr. 2016 Aug;12(3):283-290. doi: 10.1007/s12519-016-0022-1. Epub 2016 Jun 29.
10
Investigating cockroach allergens: aiming to improve diagnosis and treatment of cockroach allergic patients.研究蟑螂过敏原:旨在改善蟑螂过敏患者的诊断和治疗。
Methods. 2014 Mar 1;66(1):75-85. doi: 10.1016/j.ymeth.2013.07.036. Epub 2013 Aug 2.

引用本文的文献

1
Cockroach immunotherapy modulates dominant T-cell responses independent of allergen extract content.蟑螂免疫疗法可独立于变应原提取物成分调节主要T细胞反应。
J Allergy Clin Immunol. 2025 Jul 24. doi: 10.1016/j.jaci.2025.07.011.